National coverage for a broad range of patients
WATCHMAN is covered nationally for a broad range of patients by Centers for Medicare & Medicaid Services (CMS) and an ever-increasing number of commercial insurers.
WATCHMAN is covered for patients who need an alternative to oral anticoagulants (OACs), including those with an active lifestyle, a physical occupation, trouble maintaining a stable International Normalized Ratio (INR), or problems with treatment compliance.
CMS will cover LAAC for patients when the following criteria are met:*
1. Increased risk for stroke
CHADS2 score ≥ 2 or a CHA2DS2-VASc score ≥ 3
2. Suitable for short-term warfarin
But deemed unable to take long-term oral anticoagulation
3. Formal shared decision making interaction
Documented evidence of a formal interaction between the patient and an independent non-interventional physician using an OAC evidence-based decision tool
* documented in medical record
WATCHMAN-covered lives: ~120 million
~120 million patients covered through Medicare and commercial insurers